Licensed 503A compounding pharmacies can now prepare both topical and injectable GHK-Cu under a physicians prescription, following the April 2026 reclassification that restored injectable GHK-Cu to Category 1 status
It ended with the development of topical timolol [31,32,33,34,64,65]
Fourth, Epithalon is not approved by the FDA, EMA, or any other Western regulatory authority for any indication
sharper thinking Week 6 through Week 8: Increased energy, with regular injections Month 3 and beyond: Deeper healing effects How long each B12 shot will last is different for everyone
FormBlends frames it around comparison and decision support, with extra attention to BPC-157, dosing, provider access